Navigation Links
Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Date:5/9/2008

nactive status) certified public accountant in the state of California and is a member of the American Institute of Certified Public Accountants and the Association of Bioscience Financial Officers.

Recent Accomplishments

In the first quarter of 2008, we continued to progress our development pipeline in all three therapeutic areas of focus, including:

-- Announced positive preliminary results for RDEA806, our lead non-

nucleoside reverse transcriptase inhibitor (NNRTI), in a Phase 2a

monotherapy study in patients with human-immunodeficiency virus (HIV),

demonstrating an up to 2.0 log placebo-adjusted reduction in plasma

viral load after seven days of treatment;

-- Completed a first-in-human micro-dosing study of our second generation

NNRTI, RDEA427, and selected it as a development candidate;

-- Completed a first-in-human micro-dosing study of our second generation

MEK inhibitor, RDEA436, and selected it as a development candidate;

-- Presented preclinical data demonstrating potent activity and favorable

resistance profiles for our next generation NNRTI family of compounds

against HIV at the 15th Annual Conference on Retroviruses and

Opportunistic Infections (CROI) and the 21st International Conference

on Antiviral Research (ICAR);

-- Presented preclinical data demonstrating the potent activity and

favorable pharmacokinetic profile of our mitogen-activated ERK kinase

(MEK) inhibitor family of compounds in the treatment of cancer,

preliminary Phase 1 data demonstrating the potential for once-daily

oral dosing of RDEA119, our lead MEK inhibitor, and first-in-human

micro-dose data for RDEA436, at the American Association for Cancer

Research (AACR);

-- Established two scientific advisory boards to guide the HIV and

inflammation programs; and

-- Relocated ou
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... of studies in its neuroscience and oncology development ... 67 th American Academy of Neurology annual ... from April 18-25. The accepted abstracts feature results ... addition to investigational treatments in AbbVie,s pipeline. Presentations ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... its fourth quarter and full year 2014 financial results after ... In conjunction with the release, the Company will host a ... Eastern Time on Thursday, March 5, 2015 ... developments. Interested parties may access the live conference ...
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... Reportlinker.com announces that a new market research report is ... 10 CMOs in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html ... drivers, resistors and future outlook of CMO industry in ... analysis of the top 10 CMOs. Other leading players ...
... YORK, Jan. 25, 2011 Reportlinker.com announces that ... its catalogue: Emerging Regional Markets ... The overall emerging markets ... These regions include Latin America, China, Eastern Europe, ...
Cached Medicine Technology:Reportlinker Adds The Top 10 CMOs in China 2Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 2Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 3Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 4Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 5
(Date:2/27/2015)... February 27, 2015 Dr. Andrew Campbell, ... , is pleased to announce the expansion of Quintessa ... in Delafield. Quintessa has begun seeing patients on February ... Delafield location will offer a variety of state-of-the-art surgical ... filler injectables, micro laser peels, chemical peels, microdermabrasion, ProFractional ...
(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine posted an ... details the development of RT001, a form of topical botulinum ... trials. For those afraid of needles, the idea of a ... if the drug ultimately gets FDA approval it will be ... , “As the article notes, the size of the ...
(Date:2/27/2015)... 27, 2015 Adding to its ... pharmaceuticals, Benedict Advertising & Marketing has added Sedation ... The company’s patented NITROUSEAL® N20 closed mask and ... of sedation. , Sedation Systems, http://www.sedationsystems.com ... a new level, though it focuses primarily on ...
(Date:2/27/2015)... The winter season is here, and with it comes ... it can be harmful to the home and to one’s ... mold growth with the help of Enviro-Test. Enviro-Test, the mold ... best ways to prevent mold during the winter months. , ... mold to thrive. Mold must be removed properly, otherwise there ...
(Date:2/27/2015)... February 27, 2015 Victorian Hotel recently ... for couples who wanted to spend the auspicious day ... to get a jump on Valentine’s Day with a ... in one of their luxurious rooms. , The ... inviting guests for a mouthwatering 3 course meal at ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 3Health News:Is Topical Botox the Next Big Thing? 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2
... The ... , ... NV (PRWEB) March 23, 2010 -- The training industry’s leading authority, TrainingIndustry.com, named Corporate ... ,TrainingIndustry.com frequently reviews, conducts assessments and surveys sales training companies that provide services to ...
... , ... doctor directory, The Leading Physicians of the World has now made their elite group of ... prestigious doctors, and put themselves in the hands of an expert physician for their next ... New York, NY ...
... Thomas L. Johnson , President & CEO of Medicaid Health Plans of America (MHPA), the leading trade association solely focused on representing Medicaid health plans, issued ... ... ... ...
... , March 23 The National Alliance on Mental Illness ( NAMI ) has launched StrengthofUs.org , a new online ... to 25.  , ... , , ... ...
... chocolate, today announces the 2010 Lindt Unsung Heroes of Autism .  Three individuals have been selected from an exceptional group of ... , ... , ... ...
... March 23 Connectyx Technologies Holdings Group, Inc. ... appointed Dr. James R. Taylor to its Board ... and pharmaceutical field. He has written several publications; in addition, ... institutions, such as the University of Florida , and ...
Cached Medicine News:Health News:TrainingIndustry.com names Corporate Visions as Top 20 Sales Training Firm 2Health News:Findatopdoc.com Uses Cutting Edge Technology in Bringing the Leading Physicians of the World Directly to Your Computer For Consumers to Find a Top Doctor 2Health News:MHPA Statement on Health Reform Legislation 2Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 2Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 3Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 4Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 5Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 6Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 7Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 2Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 3Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 4Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 5Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 6Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 2Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 3Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 4Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 5
... is the soluble, extra-cellular domain of the Growth ... of the growth hormone-insulin-like growth factor (IGF) axis. ... a cleavage product of the GH receptor or ... Growth Hormone receptor cleavage /GHBP shedding is ...
... the most potent glucocorticoid produced by ... most cortisol is bound with high ... the remainder loosely bound to albumin. ... with effects in numerous physiologic systems, ...
... I (IGF-I or somatomedin C) is a 7.6 ... acts as a potent mitogen of cellular proliferation, ... receptors. In the circulation, IGF-I is bound to ... actions of IGF-I by modulating the interaction of ...
Inquire...
Medicine Products: